In Conversation

France Pharma Report June 2019
Latest Reports
France Pharma Report June 2019
- 2019
Following on from our March 2019 report, this latest issue of Healthcare & Life Sciences Review France takes a closer look at the wider French life sciences value chain and the spirit of innovation and reform sweeping the nation.   A reform-minded and business-oriented administration under President Emmanuel Macron has already made significant progress, with […]
France Pharma Report March 2019
Latest Reports
France Pharma Report March 2019
- 2019
France – under the business-minded administration of President Emmanuel Macron – has been rapidly climbing investor priority rankings in recent years.   This report examines the potential impact of a swathe of ambitious recently-approved reforms and a new mood of optimism sweeping the country. These stand to impact the entire strategic direction of the French […]
France Pharma Report
Latest Reports
France Pharma Report
- 2016
The report features interviews with the global head of Ipsen, a representative of the IMS, and of the French pricing agency CEPS. Also included are interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the country’s healthcare and pharma sectors. It offers companies, investors, policymakers, and […]
France Pharma Report
Latest Reports
France Pharma Report
- 2016
The report features interviews with the global head of Ipsen, a representative of the IMS, and of the French pricing agency CEPS. Also included are interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the country’s healthcare and pharma sectors. It offers companies, investors, policymakers, and […]
France Pharma Report
Latest Reports
France Pharma Report
- 2010
The report features interviews with the global head of Ipsen, a representative of the IMS, and of the French pricing agency CEPS. Also included are interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the country’s healthcare and pharma sectors. It offers companies, investors, policymakers, and […]
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here